Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-01-05
2009-11-17
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S262000
Reexamination Certificate
active
07618976
ABSTRACT:
Provided are processes for the preparation of sildenafil base and the citrate salt of sildenafil. Also provided are sildenafil citrate water adduct and a method of preparing pharmaceutical compositions comprising combining the sildenafil citrate and/or sildenafil citrate water adduct with at least one pharmaceutically-acceptable excipient.
REFERENCES:
patent: 4151273 (1979-04-01), Riegelman et al.
patent: 4196188 (1980-04-01), Besins
patent: 4302446 (1981-11-01), Kaplan et al.
patent: 4840799 (1989-06-01), Appelgren et al.
patent: 5250534 (1993-10-01), Bell et al.
patent: 5271944 (1993-12-01), Lee
patent: 7005520 (2006-02-01), Dunn et al.
patent: 7067660 (2006-06-01), Bunnage et al.
patent: 2002/0013464 (2002-01-01), Dunn et al.
patent: 0 463 756 (1992-01-01), None
patent: 0 812 845 (1997-12-01), None
patent: WO 98/49166 (1998-11-01), None
patent: WO 01/87888 (2001-11-01), None
patent: WO 02/102802 (2002-12-01), None
patent: WO 2004/072079 (2004-08-01), None
patent: WO 2005/013937 (2005-02-01), None
Third party observation concerning EP Application No. 07101908.7 / EP 1779852 as filed by the law firm Hoffmann Eitle with EPO on Aug. 20, 2008.
Admour, I.M. et al., “Solid Modifactions in Sildenafil Citrate,” World Meeting APV/APGI, Apr. 3, 2000, pp. 639-640.
Dunn, P.J., “Synthesis of Commercial Phosphodiesterase(V) Inhibitors,” Organic Process Research and Development, (2005) vol. 9(1) pp. 88-97, Cambridge, GB.
Shenyang Yaoke Daxue Xuebao-Shenyang Pharmaceutical University Journal, May 2002, vol. 19(3), pp. 173-175, (Chinese Only).
International Search Report of PCT/US05/000207 mailed Sep. 23, 2005.
Aronhime Judith
Braude Viviana
Shabat Shalom
Kenyon & Kenyon LLP
Kifle Bruck
Teva Pharmaceutical Industries Ltd
LandOfFree
Methods for the production of sildenafil base and citrate salt does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the production of sildenafil base and citrate salt, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the production of sildenafil base and citrate salt will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4108565